Results 111 to 120 of about 2,636 (173)

CARDIOTOXICIDADE AGUDA GRAVE POR ANTRACICLINA NA INDUÇÃO DE LEUCEMIA PROMIELOCÍTICA AGUDA

open access: yesHematology, Transfusion and Cell Therapy, 2020
M.R. Costa   +9 more
openaire   +2 more sources

Brazilian Society of Cardiology Guideline on Myocarditis - 2022. [PDF]

open access: yesArq Bras Cardiol, 2022
Montera MW   +44 more
europepmc   +1 more source

[Cardiovascular evaluation of patients undergoing cancer treatments at a clinic for childhood cancer survivors in Mexico]. [PDF]

open access: yesArch Cardiol Mex, 2020
Jiménez-Carbajal MG   +3 more
europepmc   +1 more source

Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives. [PDF]

open access: yesArq Bras Cardiol, 2022
Gonçalves-Teixeira P   +9 more
europepmc   +1 more source

Considerations on the Diagnosis and Prognosis of Primary Cardiac Lymphoma. [PDF]

open access: yesArq Bras Cardiol
Almeida TG   +3 more
europepmc   +1 more source

[Acute cardiovascular complications in a Peruvian population of oncology patients]. [PDF]

open access: yesArch Peru Cardiol Cir Cardiovasc, 2022
Valenzuela-Rodríguez G   +4 more
europepmc   +1 more source

Cardiotoxicidad tardía inducida por antraciclinas en supervivientes a leucemia aguda linfoblástica en edad pediátrica

open access: yes, 2022
Introducción: La supervivencia de los pacientes diagnosticados de leucemia aguda linfoblástica se ha incrementado de forma muy llamativa en las últimas décadas desde la introducción de las antraciclinas en los protocolos de tratamiento, siendo actualmente superior al 90%.
openaire   +1 more source

Home - About - Disclaimer - Privacy